A Phase II Trial of Bendamustine in Combination With Rituximab in Older Patients With Previously Untreated Diffuse Large B-cell Lymphoma.
Phase of Trial: Phase II
Latest Information Update: 30 May 2017
At a glance
- Drugs Bendamustine (Primary) ; Rituximab (Primary)
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- 15 Feb 2017 Status changed from active, no longer recruiting to completed.
- 10 Dec 2013 Results presented at the 56th Annual Meeting and Exposition of the American Society of Hematology.
- 02 Dec 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History